Clinical Trials Directory

Trials / Completed

CompletedNCT01701024

Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of ACYC and ACYC Vehicle Gel in the Treatment of Acne Vulgaris

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
498 (actual)
Sponsor
Bausch Health Americas, Inc. · Industry
Sex
All
Age
12 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris.

Detailed description

The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris

Conditions

Interventions

TypeNameDescription
DRUGACYCACYC active, topically applied to the face for 12 weeks
DRUGACYC vehicleACYC vehicle (placebo), topically applied to the face for 12 weeks

Timeline

Start date
2012-10-01
Primary completion
2013-05-01
Completion
2013-07-01
First posted
2012-10-04
Last updated
2018-06-04
Results posted
2017-01-10

Locations

24 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01701024. Inclusion in this directory is not an endorsement.